Search

everythinglearnresearchcommunity

for

Search:↓

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Skin color may change how alopecia areata looks under a dermoscope.

Surgeons need to understand natural hair patterns for better hair restoration results.

Early treatment is key to prevent permanent hair loss from scalp conditions that cause scarring.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

Moth-eaten alopecia is linked to various skin diseases and requires early treatment to prevent worsening.

The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.